MXPA99003982A - Compositions for reducing body odors and excess moisture - Google Patents
Compositions for reducing body odors and excess moistureInfo
- Publication number
- MXPA99003982A MXPA99003982A MXPA/A/1999/003982A MX9903982A MXPA99003982A MX PA99003982 A MXPA99003982 A MX PA99003982A MX 9903982 A MX9903982 A MX 9903982A MX PA99003982 A MXPA99003982 A MX PA99003982A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- composition according
- odor
- skin
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 150
- 206010040904 Skin odour abnormal Diseases 0.000 title claims abstract description 28
- 210000003491 Skin Anatomy 0.000 claims abstract description 71
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 49
- 239000000843 powder Substances 0.000 claims abstract description 41
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 20
- 239000006096 absorbing agent Substances 0.000 claims abstract description 15
- 239000010457 zeolite Substances 0.000 claims abstract description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003213 antiperspirant Substances 0.000 claims abstract description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 10
- 239000004599 antimicrobial Substances 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 239000007921 spray Substances 0.000 claims description 23
- 239000002245 particle Substances 0.000 claims description 18
- -1 amorphous silicas Chemical compound 0.000 claims description 16
- 239000004744 fabric Substances 0.000 claims description 16
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 238000009826 distribution Methods 0.000 claims description 11
- 230000000699 topical Effects 0.000 claims description 11
- JHLNERQLKQQLRZ-UHFFFAOYSA-N Calcium silicate Chemical compound [Ca+2].[Ca+2].[O-][Si]([O-])([O-])[O-] JHLNERQLKQQLRZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000378 calcium silicate Substances 0.000 claims description 10
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000003974 emollient agent Substances 0.000 claims description 9
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 8
- 239000001095 magnesium carbonate Substances 0.000 claims description 8
- 239000011776 magnesium carbonate Substances 0.000 claims description 8
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 8
- 210000001215 Vagina Anatomy 0.000 claims description 7
- 229960003563 Calcium Carbonate Drugs 0.000 claims description 6
- 210000004197 Pelvis Anatomy 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 6
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 5
- 150000004760 silicates Chemical class 0.000 claims description 5
- 230000001012 protector Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- LILHXQCLSOZSRO-UHFFFAOYSA-J dizinc;oxozinc;dicarbonate;tetrahydrate Chemical compound O.O.O.O.[Zn+2].[Zn+2].[Zn]=O.[Zn]=O.[Zn]=O.[O-]C([O-])=O.[O-]C([O-])=O LILHXQCLSOZSRO-UHFFFAOYSA-J 0.000 claims description 2
- 239000011667 zinc carbonate Substances 0.000 claims description 2
- 235000004416 zinc carbonate Nutrition 0.000 claims description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 2
- 230000001166 anti-perspirant Effects 0.000 abstract description 9
- 239000000969 carrier Substances 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 73
- 235000019645 odor Nutrition 0.000 description 37
- 239000000377 silicon dioxide Substances 0.000 description 35
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 18
- 229960003500 triclosan Drugs 0.000 description 17
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 16
- 229940008099 dimethicone Drugs 0.000 description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 16
- KREXGRSOTUKPLX-UHFFFAOYSA-N octadecanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O KREXGRSOTUKPLX-UHFFFAOYSA-N 0.000 description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 14
- 239000004005 microsphere Substances 0.000 description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 14
- 229920002472 Starch Polymers 0.000 description 12
- 229920002261 Corn starch Polymers 0.000 description 11
- 239000008120 corn starch Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 235000019698 starch Nutrition 0.000 description 11
- 239000008107 starch Substances 0.000 description 11
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 10
- 239000004698 Polyethylene (PE) Substances 0.000 description 10
- 239000003981 vehicle Substances 0.000 description 10
- 229940097362 Cyclodextrins Drugs 0.000 description 9
- 229920000573 polyethylene Polymers 0.000 description 9
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 8
- 229920000299 Nylon 12 Polymers 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 description 7
- 235000011399 aloe vera Nutrition 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000011787 zinc oxide Substances 0.000 description 7
- 229940118827 Zinc phenolsulfonate Drugs 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 239000003908 antipruritic agent Substances 0.000 description 6
- 239000002781 deodorant agent Substances 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 6
- 239000002480 mineral oil Substances 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 235000012222 talc Nutrition 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 6
- 210000001124 Body Fluids Anatomy 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N β-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 5
- 241001116389 Aloe Species 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 239000001116 FEMA 4028 Substances 0.000 description 4
- 206010046935 Vaginal odour Diseases 0.000 description 4
- 229960004853 betadex Drugs 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 description 3
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 229940100486 RICE STARCH Drugs 0.000 description 3
- 210000004243 Sweat Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940074928 isopropyl myristate Drugs 0.000 description 3
- OVGXLJDWSLQDRT-CEOVSRFSSA-L magnesium;(2S)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O OVGXLJDWSLQDRT-CEOVSRFSSA-L 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- HFHDHCJBZVLPGP-RWMJIURBSA-N α-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 3
- 241000282979 Alces alces Species 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 2
- 241000209761 Avena Species 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007558 Avena sp Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 210000003756 Cervix Mucus Anatomy 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010046901 Vaginal discharge Diseases 0.000 description 2
- 229960001296 Zinc Oxide Drugs 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 210000003103 Bodily Secretions Anatomy 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 229940105112 MAGNESIUM MYRISTATE Drugs 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229940105132 Myristate Drugs 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 210000004927 Skin cells Anatomy 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010066218 Stress urinary incontinence Diseases 0.000 description 1
- 229940033134 Talc Drugs 0.000 description 1
- 229960001295 Tocopherol Drugs 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N Trappsol Cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 210000003905 Vulva Anatomy 0.000 description 1
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 1
- 229940100445 WHEAT STARCH Drugs 0.000 description 1
- 229940100530 ZINC RICINOLEATE Drugs 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L Zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940118257 Zinc undecylenate Drugs 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- DVBBEGGVSYJLME-UHFFFAOYSA-N aluminum;hydrochloride Chemical compound [Al].Cl DVBBEGGVSYJLME-UHFFFAOYSA-N 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000036545 exercise Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 201000010759 hypertrophy of breast Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-M myristate Chemical compound CCCCCCCCCCCCCC([O-])=O TUNFSRHWOTWDNC-UHFFFAOYSA-M 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical class CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherols Natural products 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- RBLUZDDDFHCLDO-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C.OC(=O)CCCCCCCCC=C RBLUZDDDFHCLDO-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N γ-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
Abstract
The present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1%to about 25%, by weight of the composition, of uncomplexed cyclodextrin;and a powder carrier. The present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5%to about 60%, by weight of the composition, of a highly effective moisture absorber. The compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants. The present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites.
Description
COMPOSITIONS TO REDUCE BODY ODORS AND EXCESS OF MOISTURE
BACKGROUND OF THE INVENTION
Body odor is most commonly caused by fatty acids in the skin and bad odors from microbial sources. Human skin is naturally populated by numerous microorganisms that are nourished by various secreted substances in the skin (eccrine and apocrine sweat, and bait), skin cell debris, skin breakage products and the organisms themselves. Said unpleasant body odors are mainly organic molecules having different structures and functional groups, such as amines, acids, alcohols, aldehydes, ketones, phenolics, polycyclics, indoles, aromatics, polyaromatics, etc. They can also be made from functional groups containing sulfur, such as diol, mecaptan, sulfur and / or disulfide groups. Numerous attempts have been made to control or absorb body odors. Attempts have been made to inhibit the microbes responsible for the body odor of the wet / humid environment by which they need to proliferate and grow. Such efforts include the use of powders and / or antiperspirants. The body powders and powder-based compositions of the prior art have limited absorption capacities. Antiperspirants are not always preferred in a control product.
body odor since, although it is used throughout the body, it can interfere with the thermal regulatory process in the body by inhibiting perspiration in the action of astringent salts. Additionally, such salts can be irritating to a large number of users, particularly when applied to sensitive areas such as the pelvic region. Other deodorant compositions intended to combat / control odor associated with skin secretions, which have been described in the chemical and cosmetic literature, include emulsion sticks or suspensoid sticks, aerosols, movable ball deodorants, pads, pump sprays , and even bars of soap. Said known deodorants try to control the odor by a variety of means. For example, the patent of E.U.A. 5,525,331, to Betts, issued June 11, 1996, discloses compositions that inhibit the growth of microorganisms in bodily secretions. Deodorants can also include antibacterial compounds that help destroy / control the amount of bacteria present in the skin, thus minimizing the odor produced by the bacterial metabolism of skin secretions. Zeolites are known odor absorbers. However, said solid odor absorbers, in addition to the known activated charcoal odor absorbers, lose functionality when wet. Therefore, when they are moistened by body fluids or when they are carried in an aqueous solution, said odor absorbers are not
they prefer, since they lose their desired odor-absorbing characteristics.
In addition, zeolites can cause a "rough" feeling if they are deposited heavily on the skin. In addition to the aforementioned attempts to control and / or absorb body odor, numerous attempts have been made to cover body odors with other scents or perfumes. However, perfumes are often inadequate to completely cover body odors and can be irritating to the user when used only to control odor. Thus, there still exists a need for an improved odor and moisture absorbing composition, which is essentially free of irritating ingredients such as astringent perfumes or antiperspirants and which is safe and effective for use throughout the body. Most particularly, there is a need for a suitable composition that is left on the skin and is capable of absorbing a broad spectrum of body odors and excess moisture that are not completely suppressed by the aforementioned means. It has been found that such controlled control of body odor and moisture can be safely delivered to the entire body by the application of a composition, which is left on the skin, which incorporates odor absorption, cyclodextrin that does not form complexes.; highly effective moisture absorbing ingredients; and a powder vehicle. It has been found that a particular advantage of the present invention is the
ability to provide convenient, non-irritating odor and moisture protection when applied to concealed areas of skin such as the pelvic region, the outer vagina, the underwear area, the bra line, the skin folds, which can be very sensitive. In addition, it has been discovered that the aforementioned benefits can be supplied in a powder vehicle that also optionally provides skin assistance benefits to the user such as protection and / or wetting. These and other objects of the present invention will become apparent from the following detailed description. All percentages, ratios, and parts of the present, in the specification, examples and claims are by weight unless otherwise specified. The term "g", as used herein, refers to gram. The term "my", as used herein, refers to millimeter.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a perfume free powdery odor absorbent composition, which is safe for use on the skin, comprising from about 0.1% to about 25% by weight of the composition, of cyclodextrin which does not form complexes; and a powder vehicle. The present invention also relates to a powdered odor and moisture absorbent composition which additionally is from about 5% to about 60% by weight of the composition, of a
highly effective moisture. The compositions of the present invention may also contain additional odor control agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, anti-microbial agents and antiperspirants. The present invention also relates to the use of the aforementioned compositions in the reduction of body odor and excess moisture in hidden sites of the skin.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to an odor absorbing composition, and optionally perfume free moisture, dry powder. The present invention also relates to the use of the aforementioned powder composition in the reduction of body odor and excess moisture of the hidden sites of the skin wherein the powder composition is applied to the concealed skin. The composition can be applied directly to the hidden skin by spraying, shaking in a bottle or can and applied by hand, or applied by a cloth that is dry. The composition of the present invention comprises dry ingredients which preferably have a particle size of from about 1 to about 100 microns; most preferably from about 1 miera to about 600; and most preferably from about 1 miera to about 20 micras. As used in the
present, the particle size refers to the largest particle dimension and the last (or primary) particles. The term "hidden skin", as used herein, refers to regions of the human body covered by undergarments, such as the pelvic area, the panty area, and the bra line; and folds of the skin or intertriginous regions, where there is a continuous contact between the skin. The term "body fluids", as used herein, includes eccrine sweat, apocrine sweat, bait, reasonable moisture accumulation of transpidermal water loss, vaginal discharge, urine, and mixtures thereof. The term "excess moisture", as used herein, refers to an unwanted and / or unhealthy level of bodily fluids deposited on human skin. The term "body odor", as used herein, refers to odors that are generated as a result of the natural functioning of a human body. Such odors include, but are not limited to, odors produced by microorganisms of human skin (i.e., bacterial composition of skin secretions), upna, or vaginal discharge, and mixtures thereof. The term "total body" refers to the total external surface of human or mammalian skin.
The term "vaginal odor" refers specifically to those body odors that emanate from the pelvic region of a woman, particularly the vagina and the area of the panties. A detailed description of the essential and optional components of the present invention are given below. CICLQDEXTRINA. As used herein, the term
"cyclodextrin" includes any known cyclodextrin such as unsubstituted cyclodextrins containing from 6 to 12 glucose units, especially alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextripa and / or their derivatives and / or mixtures thereof. The term "cyclodextrin which does not form complexes" as used herein means that the cavities within the cyclodextrin of the composition of the present invention must remain essentially unfilled before application to the skin to allow the cyclodextrin to absorb Several odor molecules when the composition is applied to the skin. Preferred cyclodextrins for use in the present invention are alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and / or their derivatives. Most preferred are beta-cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta-cyclodextrin, methylated alpha-cyclodextrin or methylated beta-cyclodextrin. The most preferred is beta-cyclodextrin. It is also preferable to use a mixture of cyclodextrins. These mixtures absorb body odors more widely if subjected to complexes with a wide range of odoriferous molecules that have a
wider scale of molecular sizes. The cyclodextrin levels are from about 0.1% to about 25%, preferably from about 1% to about 20%, most preferably from about 2% to about 15%, most preferably from about 3% to about 10% by weight of the composition. Complex formation between cyclodextrin and odoriferous molecules occurs rapidly when they are moistened with body fluids. The above is convenient for the user because cyclodextrins, when found in dry skin, will not fill their cavities with other environmental scents that would otherwise make them less efficient to absorb body odors. Most particularly, in the solubilization of the cyclodextrins by body fluids, the isolated cavities become available to form inclusion complexes with the body odor molecules. In this way, finally, the availability of cyclodextrin that does not form solubilized complexes is essential for the development of effective and efficient odor control. Cyclodextrins having lower particle sizes aid in the provision of higher cyclodextrin surface availability for odor absorption and are therefore preferred. As used herein, the particle size refers to the largest dimension of the particle and the last (or primary) particles. The small particle cyclodextrins of the present invention are those having a particle size of less than about 12 microns, preferably
less than about 10 microns, and most preferably less than about 5 microns. A more complete description of the cyclodextrins, cyclodextrin derivatives and ciciodextrin particle sizes useful in the present invention can be found in the U.S. Patent. No. 5,429,628, Trihn et al., Issued July 4, 1995, which is incorporated herein by reference in its entirety. POWDER VEHICLE. The cyclodextrins and other optional components useful in the present invention should be dispersed in a pharmaceutically acceptable powder carrier for convenient, uniform application and distribution in the skin. The term "pharmaceutically acceptable", as used herein, refers to a powder suitable for topical use on the skin without undue toxicity, irritation, allergic response and the like. The powder vehicle also helps to prevent any solubilized cyclodextrin from washing away from the desired skin contact. Powdered vehicles useful in the present invention include powders known in the art that are safe for human skin. Such powders include but are not limited to corn starch (topical starch), talc, rice starch, wheat starch, tapioca starch, microcrystalline cellulose (e.g. Avicel®), aluminum starch octenyl succinate (sold by National Starch & Chemical Co. such as Dry Fio® Pure, Dry Fio® XT, and / or Dry Fio® PC), kaolin, and mixtures thereof. The preferred is corn starch. The powder vehicle of the present invention will comprise from about 10% to about 95%, preferably from
about 15% to about 80%, most preferably from about 25% to about 50% by weight of the composition.
HUMIDITY PE ABSORBENTS HIGHLY EFFECTIVE. Highly effective moisture absorbers can optionally be included in the present invention to help reduce excess moisture in hidden skin. Highly effective moisture absorbers also increase the flowability (the ability to flow without a binder due to moisture) of the compositions of the present invention. As used herein, the phrase "highly effective moisture absorbent" refers to silicas (silicon dioxide), silicates or carbonates wherein the silicates and carbonates are formed by the reaction of a carbonate or silicate with the alkali metals ( IA), alkaline earth metals (HA), or transition metals. The highly effective moisture absorbers are calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate or zinc carbonate and mixtures thereof. Some specific examples of the silicates and carbonates useful in the present invention are explained more fully in Van Nostrand Reinhold's Encvclopedia of Chemistrv. 4th Ed. Pages 155, 169, 556 and 849, (1984), which is incorporated herein by reference. Synthetic versions of the highly effective moisture absorbers are preferred, particularly as regards silicas and silicates because of the safety risks associated with crystalline silica.
Synthetic versions are formed by controlled chemical reactions in a manufacturing process rather than using a natural, mined version of those compounds that are then refined. Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker,
Clark and Daniels. Examples of synthetic calcium silicate useful in the present invention are Hubersorb "250 Hubersorb ™ 600 available from JMHuber, It is preferred that highly effective moisture absorbers comprise from about 5% to about 60%, most preferably from about 10% to about 50%, and most preferably from about 20% to about 40% by weight of the total composition ODOR CHECK CONTROL AGENTS.
Optionally, the compositions of the present invention may comprise zeolites, carbon odor control agents, sodium bicarbonate, antimicrobial agents and / or antiperspirant ingredients for control of added body odor. The term "zeolite", as used herein, refers to non-fibrous zeolites. When included in the present invention, the zeolites may be present from about 0.1% to about 25%, preferably from about 1% to about 15% by weight of the composition. A detailed description of zeolites useful in the present invention is found in the patent of E.U.A. No. 5,429,628, Trinh et al.,
issued on July 4, 1995, incorporated herein by reference in its entirety. The carbon odor control agents described in the U.S.A. No. 5,429,628 can be used in the present invention at a level of from about 0.1% to about 25% by weight of the composition.
Sodium bicarbonate is known in the art for its use as an odor absorber. An example of sodium bicarbonate and its use as an underarm deodorant is found in the U.S. patent. Do not.
4,382,079, to Marschner, issued May 3, 1983, which is incorporated herein by reference in its entirety. When included in the present invention, the sodium bicarbonate may be present from about 0.1% to about 50% by weight of the composition.
The antimicrobial agents of the present invention are selected from a group consisting of antibacterial agents, antifungal agents, and mixtures thereof. The antimicrobial agents help to destroy and / or control the amount of bacteria and / or fungi present in the skin. The preferred antimicrobial agents are zinc phenolsulfonate, zinc oxide, triclosan, Zelec® AM from DuPont, zinc ricinoleate, zinc undecylenate, and mixtures thereof. Most preferred are zinc phenolsulfonate, zinc oxide and triclosan. The triclosan is available Ciba-Geigy as Irgasan DP-300. Examples of animicrobial agents useful in the present invention are found in Cosmetic Bench Reference .. 1994 Edition, page 10, which is incorporated herein by reference. When
include in the present invention, the antimicrobials are at a level of from about 0.01% to about 25%. Preferably from about 0.1% to about 10% by weight of the present composition. When used in the armpits, anti-transplants ingredients can be included in the present invention. Examples of antiperspirants known in the art are found in the Cosmetic Bench Reference. edition
1994, page 13, which is incorporated herein by reference. When included in the present invention, antiperspirants may be present from about 0.1% to about 25% by weight of the composition. AUXILIARIES OF THE SKIN. The compositions of the present invention also optionally include skin auxiliaries. The term "skin auxiliaries", as used herein, refers to skin protectants, emollients and humectants. The skin protectors useful in the present invention are found in the Cosmetic Bench Reference. 1994 edition, page 53; and Monograph on Skin Protectant Drug Products for Over-the-Counter Human Use, 21 CFR 347. Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oats and mixtures thereof. When present, the skin protectors comprise from about 0.1% to about 805, preferably from about 0.1% to about 30%, very
preferably from about 0.1% to about 105 by weight of the composition. The emollients and humectants useful in the present invention can be found in the Cosmetic Bench Reference. 1994 edition, pages 27-32 and 46-48, incorporated herein by reference. Preferred emollients and humectants are tocopherol, tocopheryl acetate, aloe, vegetable oils, mineral oil, petrolatum, jojova oil, and mixtures thereof.
Encapsulated or spray-dried / freezing emollients are most preferred. The use of spray-dried / freeze-dried or encapsulated emollients keeps the emollients protected in the powder vehicle until they are released by cutting (such as rubbing in the armpits or clothing) or by contact with skin moisture. Examples of preferred commercial spray-dried / freeze-dried aloe useful in the present invention are freeze-dried Terra-Dry ™ aloe freeze dried or Terra-Pure ™ spray, and Terra-Spray ™ spray dried aloe from Terry Laboratories. When present, the emollients / humectants comprise from about 0.1% to about 50%, preferably from about 0.15 to about 25%, most preferably from about 0.1% to about 10% by weight of the composition. SLIDING COMPOUNDS. The present compositions may optionally comprise compounds of
glide. The term "slip compounds", as used herein, refers to compounds having unique structures that provide powdered-driven glide / lubrication characteristics and / or friction between reduced skin between intertiginous skin sites. The slip compounds of the present invention include polyethylene; nylon, polytetrafluoroethylene; silica which is in the form of ellipsoid microspheres, barrel shapes, and the like; mica, silicone (ie dimethicone) and metal stearates (ie, zinc stearate); and mixtures thereof. Preferred slip compounds are silicas which are in the form of microspheres, ellipsoids, barrel shapes and the like. The silica ellipsoids useful in the present invention are available from DuPont as ZELECR Sil. Silica microspheres are available from KOBO such as MSS-500, MSS 500/3, MSS-500 / H, MSS-500 / 3H, MSS-500 / N and MSS-500 / 3N. Additionally, it is preferred that a silica portion of the present invention is fumed silica to increase the fluidity of the powder in addition to promote the sliding characteristics. The fumed silica is available from Cabot Corporation (Cab-0-SiIR) and from Degussa (Aerosil®). When present in the compositions of the invention, the slip compounds comprise from about 0.1% to about 35%, preferably from about 1% to about 10% by weight of the composition.
AGGLUTINANTS The present invention may optionally include dry or wet binders to help promote the addition of the powder and active ingredients to the skin. The binders useful in the present invention are found in Cosmetic Bench Rerefence. 1994 edition, pages 13-14, which is incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropium myristate, magnesium myristate, silicone and mixtures thereof. Most preferred are zinc stearate, dimethicone and mixtures thereof. When included in the composition, the binders are at a level of from about 0.15 to about 25%, preferably from about 1% to about 15% by weight of the composition. ANTI-PRURÍTICOS AGENTS. Anti-pruritic agents such as those known in the art can be included in the compositions of the present invention. Example of anti-pruritic agents useful in the present invention are magnesium L-lactate, hydrocortisone, hydrocortisone acetate, and colloidal oat. A description of anti-pruritic agents is found in Handbook of Non Prescription Druqs. 10th edition, p. 529, 1993; which is incorporated herein by reference. When included in the composition, anti-pruritic agents may be present from about 0.1% to about 40% by weight of the composition. COLORING. Dyes and dyes can optionally be added to odor absorbing compositions for appearance
visual and development impression. Colorants suitable for use in the present invention are found in the Cosmetic Bench Reference. edition
1994, pages 21-22, which is incorporated herein by reference.
PROCEDURE FOR PREPARING COMPOSITIONS
The compositions of the present invention are prepared by the following steps: Create a mixture by mixing cyclodestrin, highly effective moisture absorbers (if present), in optional ingredients in a powder vehicle by a commercially available mixer such as a v-blender. , double cone mixer or ribbon mixer until the mixture is uniform; and creating a small size mix using a commercially available size reduction technique such as the hammer mill, impact mill, ball mill, or fluid energy mill until the desired particle size distribution is achieved. Although the compositions of the present invention are applied directly to the skin or hair, several applicators are useful for supplying the compositions of the hidden skin sites for maximum odor control. For example, the compositions are preferably deposited in a bottle, a can, a spray supplier, a manually activated spray supplier or in a scrub structure which is subsequently contacted with the skin to transfer the composition to the skin.
The bottles and cans known in the art are suitable for use in the delivery of the compositions of the present invention. The bottles and cans preferably comprise caps with small openings for convenient distribution of the composition. The composition of the present invention can also be supplied as a solution suspended by a spray supplier or a bottle, such as when sprayed or applied to the skin, the solvent immediately dries / volatilizes to leave a layer of powder . Examples of such suspension forms are aerosols, liquid powder suspensions, or silicone suspensions. When present in an aerosol composition, the powders of the present invention will usually be present on the scale from about 0.1% to about 15% by weight of the composition. The incorporation of an aerosol powder is explained more fully in the US patent. No. 4,078,051, to Pomot et al., Issued March 7, 1978; which is incorporated herein by reference in its entirety. Such a method, however, is not preferred for use in sensitive areas of the body such as the area of the panty or other hidden skin areas, although skin irritations may result from propellants commonly used in aerosol containers. A manually activated spray supplier is preferred which supplies the composition as a powder without the use of propellants and without the composition being in a solution form. Providers
of spray that are useful in the present invention are more fully discarded in the U.S. Patent. No. 2,450,205, to Rose, issued September 28, 1948 and the US Patent. No. 2,840,277, to Bach, issued on June 24, 1958, both incorporated herein by reference in their totalities. Any cloth structure and / or methods of preparing cloth structures commonly known in the art can be used in the present invention. The cloth comprises flexible distribution means. The term "flexible dispensing means", as used herein, includes papers, garments, nonwovens, films, foams, sponges, rolls, pads, cloths, cotton balls, and the like. Preferred cloth substrates comprise a porous material, such as nonwoven substrates, foams or sponges, which are capable of maintaining the composition within the pores of the substrates. Examples of particularly useful and inexpensive cellulosic nonwovens in the present invention are described in the U.S. Pat. No. 4,191, 609, Trokhan, issued March 4, 1980, which is incorporated herein by reference in its entirety. Techniques for combining cloth substrates with the composition of the present invention are well known in the art. Examples of common methods of combining the composition to the cloth substrate may involve coating, inversion, soaking, splashing or spraying, to the cloth substrate with the composition of the present invention.
The composition of the present invention is added to the cloth substrate at a level sufficient to provide the desired odor control and / or other desired skin benefits of the present invention.
USE OF POWDER COMPOSITION
The present invention also comprises the use of the compositions described herein in the reduction of body odor and excess moisture in a human, which comprises the application of the compositions described herein for occluded skin. The present invention also comprises the use of the compositions described herein for reducing vaginal odor in a human comprising the application of the compositions described herein in a pelvic region, outer vagina, and / or area of the panther. However, the compositions of the present invention should not be inserted into the vagina, nor applied to the vulva. An "effective amount" of the compositions of the present invention, as used herein, refers to an amount sufficient to absorb body odor and / or excess moisture to the extent that body odor is not distinguished by the sense of human smell and excess moisture is not present. The compositions of the present invention are topically applied directly to the skin or hair. The compositions are
they can provide by placing the composition in distribution means and applying an effective amount by spraying, splashing, agitating or rubbing the composition on the desired surface of the skin. Preferably, the dispensing means is a can, a spray bottle, or a preformed cloth comprising flexible dispensing means. Alternatively, the user may deposit the composition of the present invention in a cloth comprising flexible distribution means of his own choice. To do the above, the user simply selects flexible distribution means such as a cloth or sponge; transfers the composition of the present invention from a bottle or other suitable container to the selected flexible dispensing means, and applies the composition to the desired area of the body. The user can also use his hand to apply the compositions of the present invention. The user may use both the composition of the present invention as desired, depending on its intended use and degree of odor and moisture control required. The following non-limiting examples illustrate the formulations and methods of use of the present invention.
EXAMPLE I EXAMPLE II Inherently% P / P Inherently% P / P
Corn starch Corn starch (topical starch) 52.20
(topical starch) 64.80 Talc 10.00
Silica (Microspheres) 2.00 Silica (Microspheres) 3.00
Smoked silica 2.00 Smoked silica 1.00
Zinc phenolsulfonate 3.00 Zinc phenolsulfonate 3.00
Triclosan .20 Triclosan 0.30
Cyclodextrin 3.00 Cyclodextrin 13.00
Aloe Vera, dried by Aloe Vera, freeze-dried / spray 1.00 freezing / spray 0.50
Nylon-12 5.00 Nynol-12 5.00
Zinc stearate 7.00 Zinc stearate 3.00
Tocopheryl acetate 2.00 Tocopheryl acetate 2.00 Microcapsules Microcapsules Dimethicone 10.00 Mineral oil 2.00 Dimethicone 5.00
Total 100.00 Total 100.00
Examples I and II may also comprise a dye and / or anti-pruritic agent such as magnesium L-lactate.
EXAMPLE III EXAMPLE IV Ingredient% P / P Ingredient% P / P
Rice starch 54.50 Octenyl aluminum starch 30.80 Suiinate (Dry FloRpure) Mica 2.00 Silica (Ellipsoids) 4.00
Silica (Ellipsoids) 1.00 Zinc phenolsulfonate 7.00
Smoked silica 1.00 Triclosan 0.60
Triclosan 0.50 Cyclodextrin 10.00
Aluminum chlorohydrate 5.00 Gel / aloe vera oil 1.00 Ciclodextpna 6.00 Zeolite 10.00
Freeze drying / spray 1.00 Talc 13.60
Polyethylene powder 5.00 Polyethylene powder 7.00
Zinc stearate 5.00 Zinc stearate 5.00 Tocopheryl acetate oil (Vit.E. acetate) 3.00 Mineral oil 5.00
Dimethicone 10.00 Dimethicone 6.00
Nylon N-12 5.00 Total 100.00 Total 100.00
Example III may also comprise a zeolite.
EXAMPLE V EXAMPLE VI
Incedient% P / P I nq network% P / P
Tapioca starch 54.60 Corn starch (topical starch) 29.25
Talcum 4.90 Aceite flour / colloidal oat 16.35
Silica (Microspheres) 2.50 Silica (Microspheres) 2.50
Smoked silica 2.00 Silica (ellipsoids) 1.50
Zinc oxide 4.00 Caolina 8.00
Triclosan 1.00 Zinc oxide 2.00
Cyclodextrlpa 4.00 Triclosan 0.40
Gel / Aloe Vera oil 2.00 Cyclodextrin 5.00
Nylon.12 10.00 Aloe Vera Gel / Oil 2.00
Zinc stearate 6.00 Nylon-12 4.00
Isopropyl myristate 4.00 Polyethylene powder 4.00
Dimethicone 5.00 Zinc stearate 10.00 Tecoferyl acetate 5.00 Mircocapsules Dimethicone 10.00
Total 100.00 Total 100.00
Examples V and VI may also comprise sodium bicarbonate.
EXAMPLE VII EXAMPLE VIII
Inherently% P / P Ingredient% P / P
Corn starch Corn starch (topical starch) 50.80 (typical starch) 26.70
Caolin 14.50 Silica (Microspheres) 10.00
Silica (Microspheres) 2.50 Smoked silica 5.00
Silica (Ellipsoids) 1.50 Zinc Fenosulfonate 3.00
Smoked silica 0.50 Triclosan 0.20
Zinc phenolsufonate 2.00 Cyclodextrin 3.00
Triclosan 0.20 Aloe Vera, Freeze Drying / Aspersion 0.10
Clcloclodextrin 8.00 Magnesium carbonate 8.00
Gel / aloe vera oil 3.00 Nylon-12 5.00
Nylon-12 2.00 Calcium silicate 20.00
Polyethylene powder 5.00 Zinc stearate 7.00
Tocopheryl acetate 3.00 Tocopheryl acetate 2.00
Microcapsules Microcapsules Isopropyl Myristate 2.00 Dimethicone 10.00
Dimethicone 5.00 Total 100.00 Total 100.00
Examples VII and VIII may also comprise an antipruritic agent such as magnesium L-lactate.
EXAMPLE IX EXAMPLE X
Ingredient% P / P Ingredient% P / P
Corn starch 23.20 Rice starch 23.40 (topical starch) Talc 10.00 Mica 2.00
Silica (Microspheres) 10.00 Silica (Microspheres) 14.50
Smoked silica 5.00 Smoked silica 5.00
Zinc phenosulfonate 3.00 Triclosan 0.10
Triclosan 0.30 Aluminum hydrochloride 5.00
Cyclodextrin 3.00 Cyclodextrin 6.00
Aloe Vera, dried by Aloe Vera drying by Freezing spray 0.50 freezing spray 1.00
Magnesium carbonate 8.00 Calcium carbonate 10.00
Nylon-12 5.00 Polyethylene powder 3.00
Calcium silicate 20.00 Calcium silicate 10.00
Zinc stearate 3.00 Zinc stearate 7.00
Tocopheryl acetate 2.00 Tocopheryl acetate oil 3.00
Microcapsules Dimethicone 10.00 Mineral oil 2.00 Dimethicone 5.00 Total 100.00 Total 100.00
Examples IX and X may also comprise a zeolite and / or a dye.
EXAMPLE XI EXAMPLE XII
Ingredient% P / P Inherently% P / P
Starch octenyl succinate Tapioca starch 13.10 aluminum 17.40 Silica (Ellipsoids) 8.00 Talc 4.90
Smoked silica 8.00 Silica (Microspheres) 20.00 Zinc phenolsulfanate 7.00 Smoked silica 2.00
Triclosan 0.60 Zinc oxide 4.00
Cyclodextrin 10.00 Triclosan 1.00
Gel / oil of Alce Vera 1.00 Cyclodextrin 4.00
Magnesium carbonate 7.00 Aloe vera gel / oil 2.00 Calcium carbonate 3.00 Magnesium carbonate 5.00
Polyethylene powder 7.00 Calcium carbonate 4.00
Calcium silicate 15.00 Nylon-12 10.00
Zinc stearate 5.00 Calcium silicate 15.00
Mineral oil 5.00 Zinc stearate 6.00 Dimethicone 6.00 Isopropyl myristate 4.00 Dimethicone 5.00
Total 100.00 Total 100.00
EXAMPLE XIII EXAMPLE XIV
Ingredient% P / P Inherently% P / P
Corn starch Corn starch (topical starch) 10.25 (topical starch) 8.80
Oatmeal / oats Caolina 4.00 colloidal 8.35 Silica (Microspheres) 5.00 Silica (Microspheres) 5.00
Silica (Ellipsoids) 10.00 Silica (Ellipsoids) 5.00 Smoked silica 5.00 Smoked silica 5.00
Zinc oxide 2.00 Zinc phenolsulfonate 2.00
Triclosan 0.40 Triclosan 0.20
Cyclodextrin 5.00 Cyclodextrin 8.00
Gel / elk oil vera 2.00 Gel / elk oil vera 3.00 Magnesium carbonate 4.00 Magnesium carbonate 10.00
Calcium carbonate 5.00 Nylon-12 2.00
Nylon-12 4.00 Polyethylene powder 5.00
Polyethylene powder 4.00 Calcium silicate 25.00
Calcium silicate 10.00 Zinc stearate 7.00 Zinc stearate 10.00 Tocopheryl acetate 3.00 Mycrocapsules Tocopheryl acetate 5.00 Miropro isopropyl 2.00
Microcapsules
Dimethicone 10.00 Dimetícona 5.00
Total 100.00 Total 100.00
Examples XIII and XIV may also comprise sodium bicarbonate.
The above examples are prepared by the following steps: creating a mixture by mixing cyclodextrin, highly effective moisture absorbers, optional dry ingredients, and a powder vehicle in a commercially available mixer such as the v-mixer, double-cone mixer, or ribbon mixer until the mixture is uniform; reducing the particle size of the mixture using a grinding / pulverizing technique such as a hammer mill, impact mill, ball mill, or fluid energy mill; and creating a second mixture by adding any phase emollients, humectants, and / or skin protectors to the mixture, preferably using spray atomization while mixing for a more uniform dispersion. The second mixture can then be subjected to a second spraying / grinding step, and an air sorting operation is desired.
Preparation for application to the skin: The composition of the present invention, such as those formed in the examples, can be loaded onto a cloth or deposited in a spray device or can. The compositions can be applied
directly to the skin or in flexible distribution means of user selection for convenient application to the skin.
To prepare cloths: Coating, splashing, or subjecting the spray to the composition in the flexible distribution means until the desired coating or thickness of the composition is achieved in the flexible distribution means.
To prepare the spray: Deposit the composition in the selected spray pack. Close the packaging for storage until the consumer uses it. Prepare a pressurized aerosol spray, transfer the composition into a suitable container. Pressurize and seal the container after the injection of the propellant materials.
Example XV A woman with stress urinary incontinence shows that the moisture associated with that condition causes vaginal odor and discomfort. You want to reduce excess moisture and vaginal odor. After urinating, the woman cleans her outer vagina and the pelvic region with a cloth containing the composition in Example VI. The woman shows less odor after using the cloths. Alternatively, the woman uses the composition in
Example XIV and shows less odor and less moisture after using the cloths.
Example XVI A woman with large breasts shows that when she exercises, she tends to experience sweating and irritation of the skin underneath the breast. Before and after exercising, apply the composition of Example III through a manual spray bottle. Sprays the composition under her breasts and the woman shows less odor and feels more comfortable after using the sprinkling powder. Alternatively, the woman uses the composition in Example XIV and shows less odor and less moisture after using the wipes.
Example XVII A man has several allergies to cosmetic deodorants and antiperspirants and avoids the use of such products. The above results in uncontrolled and embarrassing body odor due to excess accumulated moisture. Your doctor suggests that you apply the soft, moisture absorbing odor composition of Example I or VIII. The man applies the composition throughout his body by spraying every morning after bathing, and does not suffer an allergic reaction. The man shows less odor when using the composition of example I or VIII, and shows a considerable reduction of humidity with the composition of example VIII. The man keeps a bag of cloths at work, which also contains the composition of example VIII, for a
Suitable and discreet reapplication as necessary, particularly on hot and humid days.
Example XVIII An obese woman has several abdominal skin folds where excess moisture often accumulates causing body odor. You want to reduce your body odor as well as excess moisture. The woman applies the composition of Example IV by splattering the composition of a bottle in the palm of her hand and rubbing the composition in the integuiginous regions between her skin folds as well as other hidden skin sites. The woman shows less smell. Alternatively, the woman uses the composition in Example XI and shows less odor and less moisture after using the wipes.
Claims (17)
1. - An odor absorbing composition comprising :, a) from about 0.1% to about 25% by weight of the cyclodextrin composition that does not form complexes; and b) a powder vehicle.
2. The composition according to claim 1, further characterized in that it comprises slip compounds.
3 '.- An absorbent and odor and moisture composition containing: a) from about 0.1% to about 25% by weight of the composition, of cyclodextrin that does not form complexes; b) a powder vehicle; and c) from about 5% to about 60% by weight of the composition, of a highly effective moisture absorbent.
4. The composition according to claim 3, further characterized in that the highly effective moisture absorbers are selected from the group consisting of silicates, silicas and carbonates.
5. The composition according to claim 4, characterized in that the highly effective moisture absorbers are selected from the group consisting of calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate and zinc carbonate.
6. - The composition according to any of the preceding claims, further characterized in that the cyclodextrin is selected from the group consisting of beta-cyclodextrins, derivatives of beta-cyclodextrins, alpha-cyclodextrins, derivatives of alpha-cyclodextrins, gamma-cyclodextrins, derivatives of gamma-cyclodextrins and mixtures thereof.
7. The composition according to claim 1, 2, 3, 4 or 5, further characterized in that the particle sizes are from about 1 miera to about 100 micras.
8. The composition according to claim 1, 2, 3, 4 or 5, further characterized in that the particle sizes are from about 1 to about 60 microns.
9. The composition according to claim 1, 2, 3, 4 or 5, further characterized in that the particle sizes are from about 1 to about 20 microns.
10. The composition according to claim 1, 2, 3, 4 6 5, further characterized in that the particle sizes of the cyclodextrin are from about 1 to about 12 microns.
11. The composition according to claim 1, 2, 3, 4 or 5, further characterized in that the particle sizes of the cyclodextrin are from about 1 to about 5 microns.
12. The composition according to claim 1, 2, 3, 4 6 5, further comprising selected odor control agent selected of the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial and antiperspirant agents.
13. The composition according to claim 1, 2, 3, 4 or 5, further comprising skin auxiliaries selected from the group consisting of skin protectors, emollients and humectants.
14. A preformed cloth composition, further characterized in that the composition according to claim 1, 2, 3, 4 or 5 is deposited on a cloth comprising flexible distribution means.
15. The composition according to claim 1, 2, 3, 4 or 5 supplied powder by a manually activated spray dispenser.
16. The use of an odor absorbing composition according to claim 1, for the manufacture of a topical medicament to be applied on human skin to reduce body odor in the hidden skin, a pelvic region, a vagina external and / or an area of the panties.
17. - The use of the odor and moisture absorbing composition according to claim 3 for the manufacture of a topical medicament to be applied to human skin to reduce body odor and excess moisture in the hidden skin, a region pelvic, an external vagina and / or area of the panties.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08739091 | 1996-10-28 | ||
US08736838 | 1996-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99003982A true MXPA99003982A (en) | 1999-10-14 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5780020A (en) | Methods and compositions for reducing body odor | |
US5885599A (en) | Methods and compositions for reducing body odors and excess moisture | |
WO1998018439A1 (en) | Compositions for reducing body odors and excess moisture | |
WO1998018439A9 (en) | Compositions for reducing body odors and excess moisture | |
US5861143A (en) | Methods for reducing body odors and excess moisture | |
US5861146A (en) | Method for reducing body odor | |
US6004584A (en) | Highly absorbent body powders | |
US5861144A (en) | Perfumed compositions for reducing body odors and excess moisture | |
JP2002504118A (en) | Aroma compositions and methods for reducing body odor and excess moisture | |
AU721891B2 (en) | Methods and compositions for reducing body odor | |
US5879666A (en) | Methods and compositions for reducing body odor | |
EP0939614B1 (en) | Compositions for reducing odor on skin | |
JP2001506275A (en) | Perfume-free two-phase composition and method for reducing body odor and external odor | |
US5897855A (en) | Methods and compositions for reducing body odor | |
WO2000035413A1 (en) | Methods of absorbing body odors using silica containing body powders | |
US5897856A (en) | Methods and compositions for reducing body odor | |
US5911976A (en) | Compositions for reducing body odor | |
MXPA99003982A (en) | Compositions for reducing body odors and excess moisture | |
CN1261786A (en) | Ferfumed compositions and method for reducing body odors and excess moisture | |
KR20000052842A (en) | Compositions for reducing body odors and excess moisture | |
MXPA99011488A (en) | Perfumed compositions and methods for reducing body odors and excess moisture | |
MXPA99003876A (en) | Compositions for reducing odor on skin | |
CZ441499A3 (en) | Body odors absorbing preparations containing cyclodextrin, perfume composition and powder carrier and method of their application | |
MXPA99003918A (en) | Methods and compositions for reducing body odor |